CrushSCI.com
提供学术论文选刊润色服务
Blood Advances 临时占位封面 医学
返回期刊列表

Review Cycle Records

Blood Advances

American Society of Hematology SCIE OA
2026新锐 1区2025中科院 1区 TOP2025 JCR Q1
43.8平均天数
51中位天数
2最短天数
94最长天数
7462025发文量

Paper Review Records

全部论文审稿周期

5 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

2 天

Gene therapy for sickle cell disease durability

作者Chattip Prueksapraopong; Donald B. Kohn

作者单位1. Division of Hematology/Oncology, Department of Pediatrics, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA

PDF源文件 DOI 网页
14 天

Defining durability in SCD gene therapy

作者Naif I. Aljohani

作者单位1. Department of Oncology, Adult Hematology, and Stem Cell Transplantation, King Faisal Specialist Hospital & Research Centre, Jeddah, Saudi Arabia

PDF源文件 DOI 网页
51 天

ASH clinical practice guidelines: evaluation of discordance between certainty of evidence and strength of recommendations

作者Samantha A. Hershenfeld; Robert Kunkle; Menaka Pai; Adam Cuker; Matthew C. Cheung

作者单位1. 1Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada; 2. 2American Society of Hematology, Washington, DC; 3. 3Department of Medicine, McMaster University, Hamilton, Canada; 4. 4Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; 5. 5Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

PDF源文件 DOI 网页
58 天

Bispecific antibody therapy in multiple myeloma and risk of progressive multifocal leukoencephalopathy

作者Jean-Roch Le Henaff; Loïc Le Guennec; Pauline Schiro; Kevin Bihan; Jacques Gasnault; Bruno Stankoff; Yassine Taoufik; Emmanuel Treiner; Danièle Bensoussan; Sébastien Lhomme; Anne-Sophie L’Honneur; Fabrice Bonneville; Natalia Shor; Valérie Pourcher; Béatrice Pignolet; Baptiste Lievin; Clément Javaux; Julien Le Guen; Eolia Brissot; Pierre-Antoine Limouzin; Clémence Richaud; Bruno Lioure; Thomas Wirth; Paul Petitgas; Simon Herbel; François Coustillères; Elena-Camelia Rusu; Laura Maerten; Aurore Perrot; Agnès Sommet; Damien Roos-Weil; Margaux Lafaurie; Nicolas Weiss; Guillaume Martin-Blondel; P. Rispal; R. Dhersin; V. Dubée; J. Paillassa; A.S. Valadoux; E. Piet; S. Arista; S. Ancellin; O. Paccoud; A. Serris; F. Lanternier; C. Duvivier; C. Vignals; F. Lantier; V. Delcey; A. Moussiegt; M. El Soudany; D. Brebant; I. Charachon; M. Gilbert; X. Lescure; S. Lariven; B. Denis; E. Rubenstein; C. Barsan; R. Ursu Billot; N. Crainic; F. Mechai; S. Abad; R. Courtois; A. Durrbach; C. Cauquil; Y. Quertainmont; J. Pacanowski; A. Capes; A. Banet; Q. Richier; O. Heinzlef; A. De la Selle; A.L. Houist; G. Melica; W. Vindrios; V. Esnault; M. Mahevas; G. Volle; E. Mortier; F. Finet; N. Mele; A. Chabrol; M.E. Vekemans; C. De la Porte; C. Batot; E. Chaugne; Y. Beigneux; J. Garcia; M. Dorel; J. Sarrabere; C. Tivenez; H. Chaussade; M. Mehlen; C. Cazanave; F. Dauchy; C. Vignals; E. Forcade; C. Bellissard; W. Meissner; L. Hobeika; M. Pinel; T. Sooltangos; K. Abdelmoumen; F. Bourdain; P. Da Silva; P. Gazeau; R. Paret; D. Marechal; F.M. Merrien; E. Legras; M. Tore; C. Theis; O. Tournilhac; M. Raquin; A. Zaghdoudi; S. Abidh; S. Sire; H. Frahier; G. Ahle; F. Medina; M. Blot; V. Viziolo; I. Aouissi; L. Elmansouf; G. Gaube; A. Leurs; C. Lesoil-Markowski; J. Poupart; E. Laborde; O. Epaulard; M. Le Maréchal; G. Wuillaume; O. Casez; C. Lahuna; S. Markowicz; K. Schepers; S. Devatine; T. Dequidt; T. Coman; F. Andry; A. Thomas; E. Durand; C. Badr; T. Chedid; H. Ferrand; P. Chauvet; J. Lannoy; D. Beauvais; P. Martin-Pawlowski; C. Desprez; P. Kerschen; F. Gobert; B. Andorra; M. Dion; T. Perpoint; Y. Malek; F. Hubben; P. Dumez; B. Bouchacourt; Z. Poullet; V. Eiferman; A. Crepet; N. Cassir; M. Villessot; A. Tershiphorst; P. Prin; A. Formoso; L. Corti; E. Thomas; A. Simon; L. Taillandier; C. Biron; A. Seguin; C. Antier; B. Piron; M. Prime; C. Delaunay; M. Levraut; L. Inchiappa; P. Pereyra; Corazza; O. Thomel-Rocchi; M. Chiaruzzi; F. Villa; C. Tafani; L. Mokri; O. Lacatus; P. Tattevin; M. Revest; T. Nivet; F. Benezit; L. Armange; M. Leclercq; L. Picard; E. Le Tallec; B. Cador; S. Ardois; S. Belliard; A. Bachelot; M. El Acheck; M. Marc; J. Calmettes; C. Henry; E. Pappa; V. Hean; J.P. Camdessanche; A. Zilliox; Y. Boudard; S. Cunat; P. Perrin; B. Hoellinger; N. Douiri; N. Benmoussa; F. El-Bahri; S. Viguier; C. Rual; N. Vidal; P. Delobel; X. Boumaza; L. Mazet; S. Lagarrigue; A. Frelat; G. Gombert; J. Ciron; D. Biotti; M. Rafiq; M. Roussel; J. Pariente; B. Gachet; M Tetard; A. Meybeck; B. Cappeliez; G. Perrin; Y. Conan; O. Motica; M. Lacasse; L. Letranchant; Y. Bleher; D. Merrien; G. Vergne; N. Testard; R. Collot

作者单位1. 1Department of Infectious and Tropical Diseases, Toulouse University Hospital, Toulouse, France; 2. 2Neo-I3D Research Group, Toulouse University Hospital, Toulouse, France; 3. 3Department of Medical and Clinical Pharmacology, Centre of Pharmacovigilance and Pharmacoepidemiology, Clinical Investigation Center 1436, Faculty of Medicine, Toulouse University Hospital, Toulouse, France; 4. 4Service de Médecine Intensive Réanimation à orientation neurologique, Sorbonne Université, Hôpital de la Pitié Salpêtrière, Assistance Publique–Hôpitaux de Paris, Paris, France; 5. 5OncoNeuroTox ICU Study Group, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France; 6. 6Department of Pharmacology, Clinical Investigation Center 1901, Regional Pharmacovigilance Centre, Pitié-Salpêtrière Hospital, Assistance Publique–Hôpitaux de Paris, Paris, France; 7. 7Unit of Neuroinfectious Rehabilitation, Department of Internal Medicine and Clinical Immunology, Bicêtre University Hospital, Le Kremlin-Bicêtre, Assistance Publique–Hôpitaux de Paris, Paris, France; 8. 8INSERM U1356, Gustave Roussy Institute, Villejuif, France; 9. 9Neurology Department, Sorbonne University, Paris Brain Institute, INSERM, CNRS, Pitié Salpetriere Hospital, APHP, Paris, France; 10. 10Department of Hematology and Immunology, Bicêtre Hospital, Paris-Saclay University, Assistance Publique–Hôpitaux de Paris, Le Kremlin-Bicêtre, France; 11. 11Department of Immunology, Toulouse University Hospital, Toulouse, France; 12. 12Toulouse Institute for Infectious and Inflammatory Diseases, INSERM UMR1291, CNRS UMR5051, Toulouse University, Toulouse, France; 13. 13Cell Therapy Unit, Nancy University Hospital, Vandoeuvre-lès-Nancy, France; 14. 14Department of Virology, Toulouse University Hospital, Toulouse, France; 15. 15Department of Virology, Paris Cité University, Cochin Hospital, Paris, France; 16. 16Department of Neuroradiology, Toulouse University Hospital, Toulouse, France; 17. 17Department of Neuroradiology, Pitié-Salpêtrière Hospital, Assistance Publique–Hôpitaux de Paris, Sorbonne Université, Paris, France; 18. 18Department of Infectious Diseases, Sorbonne University, Assistance Publique–Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière, Paris, France; 19. 19INSERM UMR-1136, Institut Pierre Louis d’Epidémiologie et de Santé Publique, Paris, France; 20. 20Department of Infectious and Tropical Diseases, Croix Rousse University Hospital, Hospices Civils de Lyon, Lyon, France; 21. 21Service de Gériatrie, Hôpital Européen Georges Pompidou, Assistance Publique–Hôpitaux de Paris, Paris, France; 22. 22Service d’Hématologie Clinique et Thérapie Cellulaire, Centre de Recherche de Saint-Antoine, Sorbonne University, Hôpital Saint-Antoine, Assistance Publique–Hôpitaux de Paris, INSERM, UMRs938, Paris, France; 23. 23Department of Neurology, CHU Pellegrin, Bordeaux, France; 24. 24Department of Infectious and Tropical Diseases, CHU Gabriel Montpied, Clermont-Ferrand, France; 25. 25Unité de Greffe de Cellules Souches Hématopoïétiques, Hôpitaux Universitaires de Strasbourg, Strasbourg, France; 26. 26Department of Neurology, University Hospital of Strasbourg, Strasbourg, France; 27. 27Strasbourg Neuroscience Institute, Strasbourg University, Strasbourg, France; 28. 28Institute of Genetics and Cellular and Molecular Biology, INSERM-U964, CNRS-UMR7104, University of Strasbourg, Illkirch-Graffenstaden, France; 29. 29Department of Infectious and Tropical Diseases, Quimper Hospital, Quimper, France; 30. 30Service de Maladies Infectieuses et Tropicales, Hôpital Necker-Enfants Malades, Université Paris Cité, Assistance Publique–Hôpitaux de Paris, Paris, France; 31. 31Department of Infectious Diseases, Tours University Hospital, Tours, France; 32. 32Department of Neurology, Toulon Hospital, Toulon, France; 33. 33Department of Internal Medicine, Hôpital Avicenne, Assistance Publique–Hôpitaux de Paris, Paris, France; 34. 34Department of Hematology, Toulouse University Hospital, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse University, Toulouse, France; 35. 35Hematology Unit, CHU Pitié-Salpêtrière, Sorbonne Université, Paris, France; 36. 36Médecine Intensive Réanimation, Hôpital de la Pitié-Salpêtrière, Sorbonne Université, Assistance Publique–Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Paris, France

PDF源文件 DOI 网页
94 天

In vivo evidence of effective complement modulation by TriFu in comparison to C5 inhibition and complement depletion

作者Susa Savukoski; Alina Maria Dettner; Anke Schultze; Christoph Gerber; Michael Stefan Steinberger; Rebecca Halbgebauer; Peter Melter; Arthur Dopler; Annette Palmer; Christian Karl Braun; Susanne Hafner; Bo Nilsson; Kristina Nilsson-Ekdahl; Tom Eirik Mollnes; Raban Heller; Hubert Schrezenmeier; Christoph Q. Schmidt; Markus S. Huber-Lang; Marco Mannes

作者单位1. 1Institute of Clinical and Experimental Trauma Immunology, Ulm University Medical Center, Ulm, Germany; 2. 2Institute of Experimental and Clinical Pharmacology, Toxicology and Pharmacology of Natural Products, Ulm University Medical Center, Ulm, Germany; 3. 3Department for Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany; 4. 4German Center for Child and Adolescent Health, Partner Site Ulm, Ulm, Germany; 5. 5Department of Immunology, Genetics and Pathology, Rudbeck Laboratory C5:3, Uppsala, Sweden; 6. 6Linnaeus Centre of Biomaterials Chemistry, Linnaeus University, Kalmar, Sweden; 7. 7Department of Immunology, Oslo University Hospital, University of Oslo, Oslo, Norway; 8. 8Research Laboratory, Nordland Hospital, Bodo, Norway; 9. 9Department for Trauma Surgery, Orthopaedics, Reconstructive and Septic Surgery, and Sports Traumatology, German Armed Forces Hospital Ulm, Ulm, Germany; 10. 10Institute of Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service Baden-Wuerttemberg-Hessen and University Hospital Ulm, Ulm, Germany; 11. 11Institute of Transfusion Medicine, University Hospital Ulm, Ulm, Germany

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。